Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theo de Witte

Showing results (21-30 of 151) with videos related to

Pageof 16
Sort By:
BMC Psychiatry|October 14, 2021
Benign ethnic neutropenia: an analysis of prevalence, timing and identification accuracy in two large inner-city NHS hospitalsEbenezer Oloyede, Olubanke Dzahini, Nigel Barnes, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 20, 2009
Partial T cell-depleted allogeneic stem cell transplantation following reduced-intensity conditioning creates a platform for immunotherapy with donor lymphocyte infusion and recipient dendritic cell vaccination in multiple myelomaHenriëtte Levenga, Nicolaas Schaap, Frans Maas, et al.
British Journal of Haematology|July 9, 2002
Allogeneic stem cell transplantation of adult chronic myelomonocytic leukaemia. A report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)Nicolaus Kröger, Tatjana Zabelina, Philipe Guardiola, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 10, 2002
Biodistribution and retention time of retrovirally labeled T lymphocytes in mice is strongly influenced by the culture period before infusionSebastianus Kolen, Harry Dolstra, Louis van de Locht, et al.
Annals of Hematology|September 28, 2015
Idarubicin and cytarabine in combination with gemtuzumab ozogamicin (IAGO) for untreated patients with high-risk MDS or AML evolved from MDS: a phase II study from the EORTC and GIMEMA Leukemia Groups (protocol 06013)Theo de Witte, Stefan Suciu, Liv Meert, et al.
The American Journal of Pathology|September 6, 2002
A novel, essential control for clonality analysis with human androgen receptor gene polymerase chain reactionJeroen P van Dijk, Leonie H Heuver, Bert A van der Reijden, et al.
BMC Pharmacology|September 15, 2010
Hematopoietic stem cells exhibit a specific ABC transporter gene expression profile clearly distinct from other stem cellsLeilei Tang, Saskia M Bergevoet, Christian Gilissen, et al.
Experimental Hematology|November 3, 2007
Rapid regression of bone marrow fibrosis after dose-reduced allogeneic stem cell transplantation in patients with primary myelofibrosisNicolaus Kröger, Jürgen Thiele, Axel Zander, et al.
Blood|July 5, 2003
Generation of autologous cytotoxic and helper T-cell responses against the B-cell leukemia-associated antigen HB-1: relevance for precursor B-ALL-specific immunotherapyBjorn de Rijke, Hanny Fredrix, Agnes Zoetbrood, et al.
Journal of Immunological Methods|November 13, 2007
Refinement of molecular approaches to improve the chance of identification of hematopoietic-restricted minor histocompatibility antigensBjörn de Rijke, Agnes van Horssen-Zoetbrood, Sharon Veenbergen, et al.
Pageof 16

Showing results (21-30 of 151) with videos related to

Sort By:
Pageof 16
BMC Psychiatry|October 14, 2021
Benign ethnic neutropenia: an analysis of prevalence, timing and identification accuracy in two large inner-city NHS hospitalsEbenezer Oloyede, Olubanke Dzahini, Nigel Barnes, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 20, 2009
Partial T cell-depleted allogeneic stem cell transplantation following reduced-intensity conditioning creates a platform for immunotherapy with donor lymphocyte infusion and recipient dendritic cell vaccination in multiple myelomaHenriëtte Levenga, Nicolaas Schaap, Frans Maas, et al.
British Journal of Haematology|July 9, 2002
Allogeneic stem cell transplantation of adult chronic myelomonocytic leukaemia. A report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)Nicolaus Kröger, Tatjana Zabelina, Philipe Guardiola, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 10, 2002
Biodistribution and retention time of retrovirally labeled T lymphocytes in mice is strongly influenced by the culture period before infusionSebastianus Kolen, Harry Dolstra, Louis van de Locht, et al.
Annals of Hematology|September 28, 2015
Idarubicin and cytarabine in combination with gemtuzumab ozogamicin (IAGO) for untreated patients with high-risk MDS or AML evolved from MDS: a phase II study from the EORTC and GIMEMA Leukemia Groups (protocol 06013)Theo de Witte, Stefan Suciu, Liv Meert, et al.
The American Journal of Pathology|September 6, 2002
A novel, essential control for clonality analysis with human androgen receptor gene polymerase chain reactionJeroen P van Dijk, Leonie H Heuver, Bert A van der Reijden, et al.
BMC Pharmacology|September 15, 2010
Hematopoietic stem cells exhibit a specific ABC transporter gene expression profile clearly distinct from other stem cellsLeilei Tang, Saskia M Bergevoet, Christian Gilissen, et al.
Experimental Hematology|November 3, 2007
Rapid regression of bone marrow fibrosis after dose-reduced allogeneic stem cell transplantation in patients with primary myelofibrosisNicolaus Kröger, Jürgen Thiele, Axel Zander, et al.
Blood|July 5, 2003
Generation of autologous cytotoxic and helper T-cell responses against the B-cell leukemia-associated antigen HB-1: relevance for precursor B-ALL-specific immunotherapyBjorn de Rijke, Hanny Fredrix, Agnes Zoetbrood, et al.
Journal of Immunological Methods|November 13, 2007
Refinement of molecular approaches to improve the chance of identification of hematopoietic-restricted minor histocompatibility antigensBjörn de Rijke, Agnes van Horssen-Zoetbrood, Sharon Veenbergen, et al.
Pageof 16